Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lab21 makes molecular diagnostics deal with US oncology research centre

This article was originally published in Clinica

Executive Summary

Lab21 has agreed to provide molecular diagnostic support services to the new Institute for Translational Oncology Research (ITOR) in Greenville, South Carolina. The centre is moving into the personalised cancer therapy sector and aims to translate lab research into practical applications for patients. It is part of the Greenville University Hospital System University Medical Center. Lab21 hopes the deal will help it identify and develop new biomarker panels through interactions with cancer physicians at ITOR. Last year, the Cambridge, UK-based firm set up a US subsidiary, Lab21 Inc, in Greenville (, 23 December 2009). It says the potential relationship with ITOR was one of the reasons it chose the site.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts